EU Authorized Representative for Blood Bag Manufacturers: Rule 2 Class IIb, Rule 14 Class III and the Mandate
Blood bags are named in Rule 2 of Annex VIII to Regulation (EU) 2017/745 and are class IIb. A bag that contains an anticoagulant which would be a medicinal product if used separately moves to class III under Rule 14. Both routes involve a notified body under Article 52, and a manufacturer outside the EU must designate a sole authorized representative under Article 11(1) before the first bag is placed on the Union market.
Which products this page covers
This page covers blood collection bags, transfer bags, single, double, triple and quadruple bag systems, blood bags with integrated leukocyte reduction filters, and the anticoagulant and additive solutions contained in them. Blood bags are one of the few product groups named in Annex VIII itself, which removes most of the classification debate but adds a second question about the solution inside the bag.
Rule 2: blood bags are class IIb by name
A blood bag is a non-invasive device that stores blood for eventual transfusion, so Rule 2 of Annex VIII applies:
"if they are intended for use for channelling or storing blood or other body liquids or for storing organs, parts of organs or body cells and tissues, except for blood bags; blood bags are classified as class IIb."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 2, second indent
The exception at the end of the second indent is the whole rule for this group: blood bags are class IIb. MDCG 2021-24 lists blood bags without a substance which, if used separately, can be considered to be a medicinal product as its class IIb example under Rule 2. The same guidance places tubings and blood lines for extracorporeal treatment under the class IIa branch of Rule 2, so a transfer line sold separately from the bag does not inherit class IIb.
Rule 14: bags containing an anticoagulant solution
Most collection bags contain an anticoagulant such as CPD or an additive solution. Where that substance, used separately, would be a medicinal product, Rule 14 applies:
"All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, as defined in point 2 of Article 1 of Directive 2001/83/EC, including a medicinal product derived from human blood or human plasma, as defined in point 10 of Article 1 of that Directive, and that has an action ancillary to that of the devices, are classified as class III."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 14
MDCG 2021-24 lists blood bags incorporating heparin or other substances as anticoagulant agents which, if used separately, can be considered to be a medicinal product as a class III example under Rule 14. The classification of a given bag therefore turns on whether the solution it contains is a medicinal product in its own right. That question is answered by the manufacturer with its notified body, which consults a medicines authority on the substance under Section 5.2 of Annex IX.
Filters and processing components
Integrated leukocyte reduction filters and other components that treat the blood are reached by Rule 3:
"All non-invasive devices intended for modifying the biological or chemical composition of human tissues or cells, blood, other body liquids or other liquids intended for implantation or administration into the body are classified as class IIb, unless the treatment for which the device is used consists of filtration, centrifugation or exchanges of gas, heat, in which case they are classified as class IIa."
Source: Regulation (EU) 2017/745, Annex VIII, Rule 3
MDCG 2021-24 gives particulate filtration of blood in an extracorporeal circulation system as a class IIa example under the filtration exception. Where a bag system combines a class IIb bag and a filter, Section 3.5 of Annex VIII applies and the system takes the higher class.
Classification table
| Product variant | Class | Rule | Notified body |
|---|---|---|---|
| Empty transfer bag without solution | IIb | Annex VIII, Rule 2, second indent | Yes |
| Collection bag system with anticoagulant that is a medicinal product if used separately | III | Annex VIII, Rule 14 | Yes, with medicines authority consultation under Annex IX, Section 5.2 |
| Bag system with integrated leukocyte reduction filter and anticoagulant | III | Annex VIII, Rules 14, 3 and 2; Section 3.5 | Yes |
| Blood transfusion or transfer line sold separately | IIa | Annex VIII, Rule 2, second indent (class IIa branch) | Yes |
| Blood bag intended for long-term storage of blood | IIb | Annex VIII, Rule 2, second indent | Yes |
Notified body involvement
The notified body route for class III bags with a medicinal substance is Article 52(3):
"Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI."
Source: Regulation (EU) 2017/745, Article 52(3)
For class IIb bags without a medicinal substance it is Article 52(4): Annex IX Chapters I and III with assessment of the technical documentation of at least one representative device per generic device group. Blood bags are placed on the market sterile, but sterility does not change the route here: Article 52(7)(a) concerns class I devices only, and the sterility of a class IIb or III bag is assessed within the ordinary Annex IX procedure.
The authorized representative: Article 11
Whether a blood bag manufacturer needs an EU authorized representative does not depend on the class of the product. It depends on where the manufacturer is established. Article 11(1) is the operative sentence:
"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative."
Source: Regulation (EU) 2017/745, Article 11(1)
Article 11(2) requires the mandate to be accepted in writing and to cover at least all devices of the same generic device group. Article 11(3) then lists the minimum tasks. For blood bags the representative holds a class III or class IIb certificate and, where a medicinal substance is incorporated, the record of the consultation with the medicines authority.
"(a) verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
Source: Regulation (EU) 2017/745, Article 11(3)(a)
"(b) keep available a copy of the technical documentation, the EU declaration of conformity and, if applicable, a copy of the relevant certificate, including any amendments and supplements, issued in accordance with Article 56, at the disposal of competent authorities for the period referred to in Article 10(8);"
Source: Regulation (EU) 2017/745, Article 11(3)(b)
"(g) immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"
Source: Regulation (EU) 2017/745, Article 11(3)(g)
One mandate for the European Union and Türkiye
Medex is established in Türkiye and registered in EUDAMED as an authorized representative under SRN TR-AR-000057550, so a blood bag manufacturer outside both the EU and Türkiye covers both markets with one mandate. MDCG 2022-16, footnote 1:
"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey."
Source: MDCG 2022-16, Guidance on Authorised Representatives, footnote 1
The Commission's Notice to Stakeholders of March 2022 draws the conclusion:
"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey."
Source: European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices, Section I.2
Placing the product on the Turkish market also requires registration in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, a separate service under a separate contract: see ÜTS registration for foreign manufacturers and blood bag ÜTS registration in Türkiye (Turkish).
What Medex does under the mandate
We verify that the EU declaration of conformity and technical documentation for each blood bag device exist and that the notified body procedure has been carried out, keep copies for the period in Article 10(8), register in EUDAMED and check your Basic UDI-DI records, answer competent authority requests, cooperate on corrective actions and pass complaints and suspected incidents to you without delay. A person responsible for regulatory compliance is available in-house.
A class III bag system falls in the band of €1,500 to 2,000 per year and a class IIb bag in the band of €1,200 to 1,600 per year, fixed for three years from signature. Setup is €0 and a change of representative costs nothing; see pricing and EU authorized representative cost. We do not prepare the medicinal substance dossier for the authority consultation. We are not a notified body and we do not find importers or distributors. Offices in Ankara and İstanbul.
The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.
Related pages
Related blood-contact and infusion groups with their own pages include dialyzers, infusion sets and catheters. All groups are listed on the medical device categories page. The general guide is EU authorized representative.
Frequently asked questions
What class is a blood bag under the MDR?
Class IIb. Rule 2 of Annex VIII names blood bags expressly: devices for storing blood are class IIa, except for blood bags, which are class IIb. MDCG 2021-24 gives blood bags without a medicinal substance as the class IIb example.
Why are some blood bags class III?
Because of the anticoagulant. Rule 14 places devices incorporating, as an integral part, a substance that would be a medicinal product if used separately in class III. MDCG 2021-24 lists blood bags incorporating heparin or other anticoagulant agents of that kind as a class III example.
Does the sterile condition of a blood bag bring in Article 52(7)(a)?
No. Article 52(7) applies to class I devices. A class IIb or class III blood bag is assessed by a notified body under Annex IX in any case, and sterility is covered within that procedure.
Is the transfer line sold with the bag also class IIb?
Only if it is part of the bag system. A blood line sold separately is a non-invasive device for channelling blood and falls under the class IIa branch of Rule 2; MDCG 2021-24 lists tubings and blood lines for extracorporeal treatment as class IIa.
Does one Medex mandate cover the EU and Türkiye for blood bags?
Yes. The Commission Notice of March 2022 states that manufacturers outside the EU or Turkey only need to designate one authorized representative, either in the EU or in Turkey. Medex is established in Türkiye and registered in EUDAMED.
Sources and further reading
Regulation (EU) 2017/745 on medical devices, consolidated text: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20250110
MDCG 2021-24, Guidance on classification of medical devices: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
MDCG 2022-16, Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022): health.ec.europa.eu/system/files/2022-04/md_eu-turkey_customs-union_en.pdf
Request a fixed-price EU authorized representative quote for your blood bag systems.
Request a proposal · View pricing · Appoint Medex as your authorized representative
